|By PR Newswire||
|March 19, 2014 06:34 AM EDT||
NEW YORK, March 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Worldwide Medical Polymer Markets: 2013-2020
NanoMarkets believes that medical polymers represents a major opportunity in the medical materials market over the next few years. Several factors are leading to growth in this market. Perhaps the most obvious is the aging of the population in developed nations is expanding the addressable market for polymer implants. Many polymer implants are specifically intended to assist elder patients.
Opportunity in this market has also expanded because the latest technical developments in medical polymers can fine tune implant capabilities, enable better fits for implants, and increased biocompatibility. Polymer structures can also now substitute for cartilage or enable doctors to grow a patient's tissue for transplants.
At the same time the new legal protections that followed the silicone breast implant debacle have considerably reduced the risk in the medical polymer space. And as a result of all of these factors, the medical polymer business has taken off, with the emergence of new start ups and plenty of M&A activity.
With all that is happening in this space, NanoMarkets is publishing a report that identifies current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising. As with all NanoMarkets reports in the medical materials field, this report includes a granular eight-year forecast and also profiles key suppliers and analyzes the complete supply chain for medical polymers. For the firms covered we discuss their strategies and needs along with their strengths and weaknesses. Finally, the report provides an analysis of the market for medical polymers in various important country-specific markets.
Readers of this report will gain the following:
• An analytical review of polymers used for medical applications, including developing implants, diagnostic systems, and hospital labware.
• Knowledge on current technical and market trends, including general market drivers for improvement in the healthcare sector, polymer production, and evaluation for clinical approval.
• An understanding of key medical products and their future implications.
• A pin-pointed analysis of the changing dynamics of polymer producers.
• Eight–year forecasts based on expected market growth.
• A brief technological road map for understanding industry growth.
• Profiles of major companies operating as manufacturers of medical polymers.
• Insight into important geographical locations pertaining to polymer and healthcare sectors.
• Information on the size of the medical polymer market in developed nations and the fast-growing economies in Asia, such as China and India.
• Details of the regulatory requirements of these countries for producing high-quality, medically approved polymers and their use in various applications.
• Help in making business decisions for venturing into the medical polymer market.
• Descriptive and distinctive graphics, along with concise, tabular analyses of various domains.
E.1 Opportunities in the Medical Device Market
E.2 Opportunities for the Plastics Industry
E.3 Firms and Strategies to Watch in the Medical Polymer Market
E.3.1 Bayer MaterialScience
E.3.3 Dow Corning
E.3.4 Dow Chemical
E.3.7 Eastman Chemical
E.4 Summary of Eight-Year Forecasts of the Medical Polymer Market
Chapter One: Introduction
1.1 Background to this Report
1.1.1 Boom in Thermoplastic Elastomers (TPES) and Engineered Plastics (Super Specialty Plastics)
1.1.2 Rise of Degradable Polymers
1.1.3 Important Points for Manufacturers
1.2 Scope and Objectives of this Report
1.3 Methodology and Information Sources
1.4 Plan of this Report
Chapter Two: Commercial Trends in Medical Polymers
2.1 Generic Advantages and Disadvantages of Polymers for Medical Applications
2.1.1 Advantages of Polymers in Medical Applications
2.1.2 Disadvantages of Polymers in Medical Applications
2.1.3 Replacement of Metals with Polymers in Medical Devices
2.2 Thermoplastics (PMMA, PLA, PGA, PP, PEEK, Polycarbonates)
2.2.1 Uses of Thermoplastics in Medical Applications
2.2.2 Main Suppliers of Thermoplastics for Medical Applications
2.3 Polyethylene (PE)
2.3.1 Uses of PE in Medical Applications
2.3.2 Main Suppliers of PE for Medical Applications
2.4.1 Uses of Polystyrene and Styrenics in Medical Applications
2.4.2 Main Suppliers of PS for Medical Applications
2.5 Polyvinyl Chloride
2.5.1 Uses of PVC in Medical Applications
2.5.2 Main Suppliers of PVC for Medical Applications
2.6.1 Uses of Nylon in Medical Applications
2.6.2 Main Suppliers of Nylon for Medical Applications
2.7 Other Polymers for Medical Applications
2.8 Role of Bioplastics in Medical Applications
2.9 Key Points from this Chapter
Chapter Three: Applications for Medical Polymers
3.1 Pricing and Forecast Assumptions
3.1.1 Explanation of Polymer Pricing
3.1.2 Use of Medical Polymers in Different Applications
3.2 Medical Devices and Implants
3.2.1 Current and Future Use of Polymers
3.2.2 Regenerative Medicine and Orthopedic Implants
3.2.3 Contact Lenses and Lens Implants
3.2.4 Implantable Defibrillators and Related Devices
3.2.5 Breast Implants
3.2.6 Conductive Polymer Neural Implants
3.2.7 Blood Filters
3.2.8 Other Medical Devices Using Polymers
3.3 Eight-Year Forecast of Polymers in Implants by Polymer and Implant Type
3.4 Eight-Year Forecast of Polymers in Non-Implantable Devices by Polymer and Device Type
3.4.1 Diagnostic Systems
3.5 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.5.1 Laboratory and Surgical Accessories and Disposables
3.5.2 Surgical Screws, Nails and Plates
3.5.3 Catheters and Tubing
3.5.4 Surgical Gloves
3.5.5 Sutures and Shunts
3.6 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.7 Summary of Forecasts of Medical Polymers
3.7.1 Summary Forecast of Medical Polymers by Application
3.8 Summary Forecast of Medical Polymers by Polymer Type
3.9 Key Points in this Chapter
Chapter Four: National Markets and Regulatory Factors
4.1 Generic Policy Issues Raised by Polymer Medical Devices
4.1.1 Safety Issues Related to Polymer Devices
4.1.2 Problems of Waste Disposal and Management in Medical Polymer Manufacturing
4.1.3 Healthcare Issues and an Aging Population
4.1.4 Geographical Distribution of the Markets
4.2 The Medical Polymer Market in the United States
4.2.1 Medical Polymers and the Biomaterials Access Assurance Act of 1998
4.2.2 Impact of "Obamacare"
4.2.3 Role and Impact of the FDA
4.2.4 Analysis of the Market for Medical Polymers in the U.S.
4.2.5 Eight-Year Forecasts for Medical Polymers in the U.S.
4.3 The Medical Polymer Market in Europe
4.3.1 Role and Impact of the European Commission and Other Regulatory Authorities in the European Union
4.3.2 National Regulations and Regulatory Agencies Impacting Medical Polymer Markets in the EU
4.3.3 Analysis of the Market for Medical Polymers in Europe
4.3.4 Eight-Year Forecast for Medical Polymers in Europe
4.4 The Medical Polymer Market in Japan
4.4.1 National Laws and Regulations Impacting the Medical Polymer Market in Japan
4.4.2 Analysis of Market for Medical Polymers in Japan
4.4.3 Eight-Year Forecast for Medical Polymers in Japan
4.5 The Medical Polymer Market in China
4.5.1 National Laws and Regulations Impacting the Medical Polymer Market in China
4.5.2 Impact of Chinese Industrial Policy on the Medical Polymer Market
4.5.3 Analysis of the Market for Medical Polymers in China
4.5.4 Eight-Year Forecast for Medical Polymers in China
4.6 The Medical Polymer Market in India
4.6.1 National Laws and Regulations Impacting the Medical Polymer Market in India
4.6.2 Analysis of the Market for Medical Polymers in India
4.6.3 Eight-Year Forecast for Medical Polymers in India
4.7 Other Notable National Markets for Medical Polymers
4.7.1 The Medical Polymer Market in Canada
4.7.2 The Medical Polymer Market in Australia
4.7.3 The Medical Polymer Market in South Korea
4.8 Summary of Eight-Year Forecasts of Medical Polymers by Country
Acronyms and Abbreviations Used In this Report
About the Author
List of Exhibits
Exhibit E-1: Summary Forecast of Medical Polymers by Application ( US$ Millions)
Exhibit 2-1: Important Advantages of Polymers and Their Current Applications
Exhibit 2-2: Thermoplastics - Properties and Uses
Exhibit 2-3: Common Suppliers of Thermoplastics
Exhibit 2-4: Opportunities for Different PE Grades
Exhibit 2-5: Different Suppliers of Polyethylene Products and their Features
Exhibit 2-6: Requirements and Medical Applications for Various Types of PS
Exhibit 2-7: Suppliers Of GPPS, HIPS, and SPS Products for Medical Applications and their Trade Names
Exhibit 2-8: Suppliers and Characteristics of Flexible, Rigid and Semi-rigid Medical Grades of PVC
Exhibit 2-9: Nylon Products and Manufacturers
Exhibit 2-10: Medical Devices and Implants Made from Polyurethanes
Exhibit 2-11: Leading Teflon products, Their Manufacturers, and Application Areas
Exhibit 3-1: Pricing of Polymers and Polymer-Based Medical Products
Exhibit 3-2: Approximate Market Share of Different Polymer Types in Each Application
Exhibit 3-3: Selected Polymeric Orthopedic Products, their Manufacturers and Opportunities
Exhibit 3-4: Approved Breast Implants and their Market Opportunities
Exhibit 3-5: Overview of Important Blood Filters
Exhibit 3-6: Overview of Selected Wound Dressing Materials
Exhibit 3-7: Orthopedic Implants and Regenerative Medicines Forecast
Exhibit 3-8: Forecast of Polymer Use In Lens Implants
Exhibit 3-9: Forecast of Polymer Use in Contact Lenses
Exhibit 3-10: Forecast of Polymer Use in Implantable Defibrillators
Exhibit 3-11: Forecast of Polymer Use In Breast Implants
Exhibit 3-12: Forecast of Conductive Polymer Use In Neural Implants
Exhibit 3-13: Forecast of Polymer Use In Blood Filters
Exhibit 3-14: Forecast of Polymer Use In Other Medical Devices
Exhibit 3-15: Polymers Used in Diagnostic Devices and Their Future Opportunities
Exhibit 3-16: Forecast of Polymer Use In Diagnostic Devices
Exhibit 3-17: Forecast of Polymer Use In Automated Analyzers
Exhibit 3-18: Forecast of Polymer Use In Homecare Diagnostic Devices
Exhibit 3-19: Forecast of Polymer Use In Point-of-Care (POC) Diagnostics
Exhibit 3-20: Overview of Important Polymers for Multiple-Use and Disposable Labware Fabrication
Exhibit 3-21: Leading Labware Manufacturers and Their Brands and Market Potential
Exhibit 3-22: Selected Catheter and Tubing Products
Exhibit 3-23: Surgical Gloves and Their Specifications
Exhibit 3-24: Forecast of Polymer Use In Surgical Screws, Nails and Plates
Exhibit 3-25: Forecast of Polymer Use In Catheters and Tubing
Exhibit 3-26: Forecast of Polymer Use In Surgical Gloves
Exhibit 3-27: Forecast of Polymer Use In Sutures and Shunts
Exhibit 3-28: Summary Forecast of Medical Polymers by Application (US $Millions)
Exhibit 3-29: Summary Forecast by Top Polymer Types (U.S.$ Millions)
Exhibit 4-1: Key Industry Issues, Their Impacts, and Probable Solutions
Exhibit 4-2: Important U.S. Regulations Affecting Medical Polymers
Exhibit 4-3: Key Players in the U.S. Medical Polymer Industry Responding to Major Trends
Exhibit 4-4: Eight-Year Forecast of Medical Polymers in the U.S. (US$ Millions)
Exhibit 4-5: Key EC Regulations and Their Significance
Exhibit 4-6: Recent Technology Developments in Europe
Exhibit 4-7: Eight-Year Forecast for Medical Polymers in Europe (US$ Millions)
Exhibit 4-8: Important Regulations in Japan and Their Impact on the Medical Polymers Market
Exhibit 4-9: Recent Technology Developments in Japan
Exhibit 4-10: Eight-Year Forecast for Medical Polymers in Japan (US $Millions)
Exhibit 4-11: Key Impacts of CFDA Policies and Opportunities for Policy Improvement in China
Exhibit 4-12: Recent Technology Developments in China
Exhibit 4-13: Eight-Year Forecast for Medical Polymers in China (US $Millions)
Exhibit 4-14: Key Regulatory Impacts and Opportunities for Policy Improvement in India
Exhibit 4-15: Recent Technology Developments in India
Exhibit 4-16: Eight-Year Forecast for Medical Polymers in India (US $Millions)
Exhibit 4-17: Regulatory Scenario and Industry Opportunities in Other Markets
Exhibit 4-18: Global Eight-Year Forecast for Medical Polymers Broken Out by Country/Region
To order this report: Worldwide Medical Polymer Markets: 2013-2020
Contact Clare: [email protected]
Intl: +1 339-368-6001
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., will discuss how these tools can be leveraged to develop a lasting competitive advanta...
Mar. 25, 2017 07:45 AM EDT Reads: 2,513
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
Mar. 25, 2017 06:45 AM EDT Reads: 996
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
Mar. 25, 2017 06:45 AM EDT Reads: 676
SYS-CON Events announced today that HTBase will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. HTBase (Gartner 2016 Cool Vendor) delivers a Composable IT infrastructure solution architected for agility and increased efficiency. It turns compute, storage, and fabric into fluid pools of resources that are easily composed and re-composed to meet each application’s needs. With HTBase, companies can quickly prov...
Mar. 25, 2017 06:45 AM EDT Reads: 2,658
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Mar. 25, 2017 06:30 AM EDT Reads: 1,462
What if you could build a web application that could support true web-scale traffic without having to ever provision or manage a single server? Sounds magical, and it is! In his session at 20th Cloud Expo, Chris Munns, Senior Developer Advocate for Serverless Applications at Amazon Web Services, will show how to build a serverless website that scales automatically using services like AWS Lambda, Amazon API Gateway, and Amazon S3. We will review several frameworks that can help you build serverle...
Mar. 25, 2017 06:15 AM EDT Reads: 1,581
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Mar. 25, 2017 05:30 AM EDT Reads: 1,340
Culture is the most important ingredient of DevOps. The challenge for most organizations is defining and communicating a vision of beneficial DevOps culture for their organizations, and then facilitating the changes needed to achieve that. Often this comes down to an ability to provide true leadership. As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership abi...
Mar. 25, 2017 05:00 AM EDT Reads: 10,828
After more than five years of DevOps, definitions are evolving, boundaries are expanding, ‘unicorns’ are no longer rare, enterprises are on board, and pundits are moving on. Can we now look at an evolution of DevOps? Should we? Is the foundation of DevOps ‘done’, or is there still too much left to do? What is mature, and what is still missing? What does the next 5 years of DevOps look like? In this Power Panel at DevOps Summit, moderated by DevOps Summit Conference Chair Andi Mann, panelists l...
Mar. 25, 2017 05:00 AM EDT Reads: 9,622
The essence of cloud computing is that all consumable IT resources are delivered as services. In his session at 15th Cloud Expo, Yung Chou, Technology Evangelist at Microsoft, demonstrated the concepts and implementations of two important cloud computing deliveries: Infrastructure as a Service (IaaS) and Platform as a Service (PaaS). He discussed from business and technical viewpoints what exactly they are, why we care, how they are different and in what ways, and the strategies for IT to transi...
Mar. 25, 2017 05:00 AM EDT Reads: 5,927
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
Mar. 25, 2017 03:00 AM EDT Reads: 5,665
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Mar. 25, 2017 02:00 AM EDT Reads: 2,791
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor - all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
Mar. 25, 2017 01:45 AM EDT Reads: 1,438
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Mar. 25, 2017 12:15 AM EDT Reads: 1,587
What sort of WebRTC based applications can we expect to see over the next year and beyond? One way to predict development trends is to see what sorts of applications startups are building. In his session at @ThingsExpo, Arin Sime, founder of WebRTC.ventures, will discuss the current and likely future trends in WebRTC application development based on real requests for custom applications from real customers, as well as other public sources of information,
Mar. 25, 2017 12:00 AM EDT Reads: 511